
Andover, Massachusetts
Research Site
Andover, MA Site Statistics
- Pfizer’s 70-acre, 3 million square foot site in Andover, MA opened in 1988 and has expanded to support one of the largest biotherapeutic and vaccine portfolios in the industry.
- The site combines state-of-the-art R&D capabilities with flexible, multi-product manufacturing capabilities, which allow our colleagues to advance discovery and early development efforts, product and process development, clinical supply and operations, and commercial manufacturing for biotherapeutics and vaccines.
- The site’s therapeutic areas of focus include Inflammation & Immunology, Internal Medicine, Oncology and Vaccines.
In 2007, Andover became the first biotechnology facility in New England to receive OSHA's Voluntary Protection Program (VPP) certification for its work in building a culture of safety.
Learn more about career opportunities in Andover.





